Methylhexanamine

Also known as 4-methylhexan-2-amine, methylhexamine, 1,3-dimethylamylamine, dimethylamylamine

Methylhexanamine (also known as methylhexamine, 1,3-dimethylamylamine, 1,3-DMAA, dimethylamylamine, and DMAA; trade names Forthane and Geranamine) is an indirect sympathomimetic drug invented and developed by Eli Lilly and Company and marketed as an inhaled nasal decongestant from 1948 until it was voluntarily withdrawn from the market in the 1980s.

Key facts

Drug.Verifiedfields: changed
Drug.Watchedfields: changed
Drug.IUPAC_name: 4-Methylhexan-2-amine
Drug.image: Geranamine.svg
Drug.image_class: skin-invert-image
Drug.image2: Geranamine-3D-balls.png
Drug.image_class2: bg-transparent
Drug.legal_AU: S10
Drug.legal_BR: F2
Drug.legal_US: Unapproved drug; use in dietary supplements, food, or medicine is unlawful.
Drug.routes_of_administration: Nasal spray, oral
Drug.elimination_half life: ~8.5 hours
Drug.CAS_number: 105-41-9
Drug.UNII: X49C572YQO
Drug.ATC_prefix: None
Drug.PubChem: 7753
Drug.ChemSpiderID: 7467
Drug.C: 7

via Wikipedia infobox

Chemical data

Formula: C7H17N
Molecular weight: 115.22 g/mol
IUPAC name: 4-methylhexan-2-amine
SMILES: CCC(C)CC(C)N
InChIKey: YAHRDLICUYEDAU-UHFFFAOYSA-N
XLogP: 1.9
Polar surface area: 26 Å²
H-bond donors: 1
H-bond acceptors: 1
Formal charge: 0

via PubChem

Gallery (2)

Available in 19 languages

via Wikidata sitelinks · CC0